Taconic Capital Advisors’s ProKidney PROK Stock Holding History

Taconic Capital Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500,003	Closed	-$4.94M	–	726
2022 Q1	$4.94M	Buy	500,003 +3	+0%	+$30	0.13%	171
2021 Q4	$4.95M	Hold	500,000	–	–	0.14%	149
2021 Q3	$4.9M	Buy	500,000 +75,100	+18%	+$739K	0.13%	125
2021 Q2	$4.3M	Buy	+424,900	New	+$4.3M	0.1%	137

Other funds holding PROK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Taconic Capital Advisors's PROK Position: Q2 2022 in Review

Taconic Capital Advisors sold out of ProKidney (PROK) in Q2 2022, closing a stake of 500,003 shares — an estimated $4.94M sold.

Taconic Capital Advisors first reported a position in PROK in Q2 2021 and held it in 4 quarters. The position peaked at $4.95M in Q4 2021. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

Taconic Capital Advisors reported no remaining ProKidney position as of Q2 2022 after selling out during the quarter.
Taconic Capital Advisors sold 500,003 ProKidney shares in Q2 2022, an estimated $4.94M.
Taconic Capital Advisors first reported a position in ProKidney in Q2 2021 and held it in 4 quarters.
Taconic Capital Advisors's ProKidney position peaked at $4.95M in Q4 2021.
67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Taconic Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.